JPWO2020223356A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020223356A5
JPWO2020223356A5 JP2021565001A JP2021565001A JPWO2020223356A5 JP WO2020223356 A5 JPWO2020223356 A5 JP WO2020223356A5 JP 2021565001 A JP2021565001 A JP 2021565001A JP 2021565001 A JP2021565001 A JP 2021565001A JP WO2020223356 A5 JPWO2020223356 A5 JP WO2020223356A5
Authority
JP
Japan
Prior art keywords
seq
raav
expression cassette
sequence
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021565001A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022530833A (ja
JP7585233B2 (ja
JP2022530833A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/030484 external-priority patent/WO2020223356A1/en
Publication of JP2022530833A publication Critical patent/JP2022530833A/ja
Publication of JPWO2020223356A5 publication Critical patent/JPWO2020223356A5/ja
Publication of JP2022530833A5 publication Critical patent/JP2022530833A5/ja
Application granted granted Critical
Publication of JP7585233B2 publication Critical patent/JP7585233B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021565001A 2019-04-30 2020-04-29 ポンペ病の治療のために有用な組成物 Active JP7585233B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962840911P 2019-04-30 2019-04-30
US62/840,911 2019-04-30
US201962913401P 2019-10-10 2019-10-10
US62/913,401 2019-10-10
PCT/US2020/030484 WO2020223356A1 (en) 2019-04-30 2020-04-29 Compositions useful for treatment of pompe disease

Publications (4)

Publication Number Publication Date
JP2022530833A JP2022530833A (ja) 2022-07-01
JPWO2020223356A5 true JPWO2020223356A5 (https=) 2023-05-08
JP2022530833A5 JP2022530833A5 (https=) 2023-05-08
JP7585233B2 JP7585233B2 (ja) 2024-11-18

Family

ID=73029176

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021564730A Pending JP2022530824A (ja) 2019-04-30 2020-04-29 ポンペ病の治療のために有用な組成物
JP2021565001A Active JP7585233B2 (ja) 2019-04-30 2020-04-29 ポンペ病の治療のために有用な組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021564730A Pending JP2022530824A (ja) 2019-04-30 2020-04-29 ポンペ病の治療のために有用な組成物

Country Status (16)

Country Link
US (2) US20220193207A1 (https=)
EP (2) EP3980548A4 (https=)
JP (2) JP2022530824A (https=)
KR (2) KR20220004696A (https=)
CN (2) CN114127275A (https=)
AU (2) AU2020266829A1 (https=)
BR (2) BR112021021792A2 (https=)
CA (2) CA3134523A1 (https=)
CL (2) CL2021002754A1 (https=)
CO (2) CO2021016198A2 (https=)
IL (2) IL287522A (https=)
MX (2) MX2021013364A (https=)
PH (2) PH12021552638A1 (https=)
SG (2) SG11202111400TA (https=)
TW (1) TW202100541A (https=)
WO (2) WO2020223362A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI3635009T3 (fi) 2017-06-07 2026-04-07 Regeneron Pharma Koostumuksia ja menetelmiä entsyymien internalisoimiseksi
JP7779653B2 (ja) 2018-02-07 2025-12-03 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 治療用タンパク質送達のための方法および組成物
EP3793591A1 (en) 2018-05-17 2021-03-24 Regeneron Pharmaceuticals, Inc. Anti-cd63 antibodies, conjugates, and uses thereof
CN115087458A (zh) * 2019-10-10 2022-09-20 阿米库斯治疗学公司 变体igf2构建体
KR20230010255A (ko) * 2020-05-14 2023-01-18 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 폼페병의 치료에 유용한 조성물
US20230220069A1 (en) 2020-06-17 2023-07-13 The Trustees Of The University Of Pennsylvania Compositions and methods for treatment of gene therapy patients
EP4430201A4 (en) * 2021-11-12 2026-04-08 Univ Pennsylvania Gene therapy for the treatment of mucopolysaccharidosis IIIA
NL2031676B1 (en) * 2022-04-22 2023-11-07 Univ Erasmus Med Ct Rotterdam Gene therapy for Pompe Disease
WO2024003687A1 (en) * 2022-06-28 2024-01-04 Pfizer Inc. Nucleic acids encoding acid alpha-glucosidase (gaa) and vectors for gene therapy
WO2024151982A1 (en) * 2023-01-13 2024-07-18 Amicus Therapeutics, Inc. Gene therapy constructs for the treatment of pompe disease
CN116693633B (zh) * 2023-02-21 2023-12-22 广州派真生物技术有限公司 腺相关病毒突变体及其应用
WO2025171163A1 (en) * 2024-02-06 2025-08-14 Duke University Compositions for and methods of treating lysosomal storage diseases

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE521701T1 (de) * 2003-01-22 2011-09-15 Univ Duke Verbesserte konstrukte zur expression lysosomaler polypeptide
CN1922313B (zh) * 2004-02-10 2011-10-26 生物马林医药公司 酸性α-糖苷酶及其片段
US20090117091A1 (en) * 2006-11-13 2009-05-07 Lebowitz Jonathan Methods for treating pompe disease
EP2623599B1 (en) * 2007-10-04 2019-01-02 Roche Innovation Center Copenhagen A/S Micromirs
HRP20170698T1 (hr) * 2008-05-07 2017-09-22 Biomarin Pharmaceutical Inc. Lizosomski usmjereni peptidi i njihove uporabe
US8466340B2 (en) * 2009-02-18 2013-06-18 Amicus Therapeutics, Inc. Mouse model for pompe disease and methods of use thereof
JP5755569B2 (ja) * 2009-02-25 2015-07-29 セファイド 肺癌を検出する方法
EP2475376B1 (en) * 2009-06-17 2016-03-30 BioMarin Pharmaceutical Inc. Formulations for lysosomal enzymes
US9279007B2 (en) 2010-11-22 2016-03-08 Amicus Therapeutics, Inc. Signal sequences to improve protein expressions and secretion of recombinant enzymes and other proteins
WO2012070014A2 (en) * 2010-11-26 2012-05-31 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Identification of novel cell surface markers for pancreatic progenitor cells and definite endodermal cells
GB201103062D0 (en) * 2011-02-22 2011-04-06 Isis Innovation Method
LT2714752T (lt) * 2011-05-27 2018-03-12 Amicus Therapeutics, Inc. Nukreipiančių peptidų kopuliavimo ant rekombinantinių lizosominių fermentų būdai, skirti lizosominio kaupimo ligų gydymo pagerinimui
WO2013013019A2 (en) * 2011-07-21 2013-01-24 Alnylam Pharmaceuticals, Inc. Lysosomal polypeptides, methods of making and using
CN107405411A (zh) * 2014-05-01 2017-11-28 华盛顿大学 使用腺病毒载体的体内基因改造
KR102423442B1 (ko) * 2015-12-11 2022-07-20 캘리포니아 인스티튜트 오브 테크놀로지 아데노-관련 바이러스를 지시하기 위한 타겟팅 펩타이드
IL325155A (en) * 2016-03-30 2026-02-01 Amicus Therapeutics Inc Formulations containing recombinant acid alpha-glucosidase
EP3293259A1 (en) 2016-09-12 2018-03-14 Genethon Acid-alpha glucosidase variants and uses thereof
EP3293260A1 (en) * 2016-09-12 2018-03-14 Genethon Acid-alpha glucosidase variants and uses thereof
MX2019002842A (es) * 2016-09-12 2019-08-29 Genethon Variantes de alfa-glucosidasa acida y usos de las mismas.
CA3057899A1 (en) * 2017-03-27 2018-10-04 Vrije Universiteit Brussel Diaphragm-specific nucleic acid regulatory elements and methods and use thereof
JP2018198611A (ja) * 2018-08-03 2018-12-20 ウニベルシダッド アウトノマ デ バルセロナ 脂肪組織に形質導入するのに有用なアデノ随伴ウイルスベクター

Similar Documents

Publication Publication Date Title
JP7776477B2 (ja) 転写調節要素及びその使用
KR102526711B1 (ko) 고효율 게놈 편집을 위한 아데노-관련 바이러스 벡터 변이체 및 이의 방법
ES2859605T3 (es) Procedimientos y composiciones para tratar enfermedades del cerebro
CN113316639A (zh) 用于治疗庞贝氏病的治疗性腺相关病毒
SG11202111400TA (en) Compositions useful for treatment of pompe disease
CN112225793B (zh) 一种溶酶体靶向肽及其融合蛋白、携带融合蛋白编码序列的腺相关病毒载体及其应用
CA3121528A1 (en) Anellosomes and methods of use
JPWO2020223356A5 (https=)
US20240002462A1 (en) Treatment of neuropathy with igf-1-encoding dna constructs and hgf-encoding dna constructs
JPWO2020223362A5 (https=)
EP4509606A1 (en) Nucleic acid construct for treating hereditary coagulation factor deficiency and use thereof
US11510999B2 (en) Treatment of neuropathy with DNA constructs expressing IGF-1 isoforms
US11001860B2 (en) Poxvirus-derived promoter, and vector comprising same
JPWO2021231579A5 (https=)
US20240335506A1 (en) Aqp1 gene therapy to prevent radiation induced salivary hypofunction
CN115927401B (zh) 编码nadh泛醌氧化还原酶4号亚基的核酸及其用途
JPWO2021081217A5 (https=)
JP2025523952A (ja) 筋肉特異的調節カセット
Rasoul et al. Use of viral vector to deliver IL-15 for cancer therapy: An overview
CN115710586B (zh) 编码nd4的核酸及其在制备药物中的用途
JPWO2020038473A5 (https=)
CN115710585B (zh) 编码nd4的核酸及其用途
CN114507692B (zh) 用于治疗法布里病的腺相关病毒载体及其用途
WO2024216244A2 (en) Targeting aav capsids, methods of manufacturing and using same
WO2026072752A1 (en) Rod-derived cone viability factor fusion protein